뉴스 검색결과 32건

• 
  SyntekaBio Enters ‘Assetization Phase’ for AI Asset Program 2026.01.21
• 
  Syntekabio wins SI deal from HYBE’s Weverse unit 2025.12.17
• 
  SyntekaBio Licenses Out Five AI-Designed Multispecific Antibodies to Panolos 2025.12.16
• 
  SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies 2025.12.05
• 
  SyntekaBio CEO, “No AI Drug Leader, a Chance for Us” 2025.12.02
• 
  Peptron Jumps on Lilly Hopes; CORESTEMCHEMON Falls on Rights Issue[K-Bio Pulse] 2025.11.28
• 
  ABL Bio Boosts Tech Export Potential Amid Big Deal, Biotech Demand Soars[K-bio Pulse] 2025.11.19
• 
  SyntekaBio posts about 1.7 billion won in YTD sales through Q3 2025.11.19
• 
  GV1001 Readout Nears; GemVax Surges, G2GBIO Rallies[K-Bio Pulse] 2025.11.16
• 
  On Drug Momentum, ABPROBIO & Ildong Hit Limit Up; Syntekabio Jumps[K-Bio Pulse] 2025.11.13